Cambridge healthtech institute's third annual conference on human genetic variation

Pharmacogenomics

Volumn 2, Issue 1, 2001, Pages 79-84

  Diehl, Scott R ^a   White, P Scott ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Gene mapping; Genetic disease; Genetic epidemiology; Linkage disequilibrium; SNP discovery; SNP genotyping; SNP scoring

Indexed keywords

ACCURACY; ALLELE; AUTOMATION; BIOENGINEERING; BIOTECHNOLOGY; CONFERENCE PAPER; CONTROLLED STUDY; COST; DATA BASE; DISEASE PREDISPOSITION; EPIDEMIOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC DISORDER; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENETICS; LABORATORY; MOLECULAR GENETICS; MORBIDITY; MORTALITY; PHARMACOGENOMICS; PHYSICIAN; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TEAMWORK; THEORY;

GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

EID: 0034942646     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.2.1.79     Document Type: Conference Paper

References (7)

1. The future of genetic studies of complex human diseases
2. Genomics and medicine: An anticipation. From boolean Mendelian genetics to multifactorial molecular medicine
3. Pharmacogenetics and the practice of medicine
4. Pharmacogenomics: Hope or hype?
5. Human genome research. SNP mappers confront reality and find it daunting
6. Linkage disequilibrium of interleukin-1 genetic polymorphisms with early-onset periodontitis
7. Pharmacogenomics and schizophrenia